Compare Duolingo Inc (DUOL) vs Mesoblast Limited (MESO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Duolingo Inc vs Mesoblast Limited — how do they compare? Duolingo Inc trades at $134.6 (market cap $6.34B), while Mesoblast Limited trades at $16.68 (market cap $2.21B). The key difference: Duolingo Inc is far larger — about 2.9× Mesoblast Limited's market cap, and Mesoblast Limited is trading nearer its 52-week high, Duolingo Inc nearer its low. Which is the better fit depends on your goals.
| DUOL | MESO | |
|---|---|---|
Market Cap | $6.34B | $2.21B |
Sector | Technology | Technology |
52-Week High | $369.19 | $20.96 |
52-Week Low | $90.03 | $12.88 |
Enterprise Value | $5.11B | $2.21B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Duolingo Inc
Duolingo Inc is a mobile learning platform to learn languages and the top-grossing app in the Education category on both Google Play and the Apple App Store. It has three predominant sources of revenue
Read more on DUOL →About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →
